{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:52Z","timestamp":1793146612120,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05470-9","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:18:24Z","timestamp":1773994704000},"page":"5084-5092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Site-specific limitations of ctDNA in PDAC surveillance: imaging detects pulmonary and local recurrence missed by liquid biopsy"],"prefix":"10.1007","volume":"51","author":[{"given":"Sherif B.","family":"Elsherif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kamaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"issue":"1","key":"5470_CR1","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.soi.2024.100116","volume":"2","author":"EM Dickey","year":"2025","unstructured":"Dickey EM, Martos MP, Yanala U, Corona A, Ezenwajiaku N, Pizzolato J, Franceschi D, Livingstone AS, Terrero G, Hester CA, Merchant NB, Datta J, Hosein PJ. Utility of tumor-informed circulating tumor DNA for detection of minimal residual disease after curative-intent therapy in localized pancreatic cancer. Surgical Oncology Insight 2025;2(1):100116. doi: https:\/\/doi.org\/10.1016\/j.soi.2024.100116","journal-title":"Surgical Oncology Insight"},{"issue":"4","key":"5470_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.26502\/jsr.10020173","volume":"4","author":"M Abdelrahim","year":"2021","unstructured":"Abdelrahim M, Esmail A, Xu J, Katz TA, Sharma S, Kalashnikova E, Malhotra M, Olshan P, Billings PR, Aleshin A. Early relapse detection and monitoring disease status in patients with early-stage pancreatic adenocarcinoma using circulating tumor DNA. Journal of Surgery and Research 2021;4(4):602\u2013615.","journal-title":"Journal of Surgery and Research"},{"issue":"10","key":"5470_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/oncolo\/oyae155","volume":"29","author":"GP Botta","year":"2024","unstructured":"Botta GP, Abdelrahim M, Drengler RL, Aushev VN, Esmail A, Laliotis G, Brewer CM, George GV, Abbate SM, Chandana SR, Tejani MA, Malla M, Bansal D, Rivero-Hinojosa S, Spickard E, McCormick N, Cecchini M, Lacy J, Fei N, Kasi PM, Kasi A, Dayyani F, Hanna DL, Sharma S, Malhotra M, Aleshin A, Liu MC, Jurdi A. Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. Oncologist 2024;29(10):859\u2013869. doi: https:\/\/doi.org\/10.1093\/oncolo\/oyae155","journal-title":"Oncologist"},{"issue":"17","key":"5470_CR4","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1158\/1078-0432.Ccr-18-3477","volume":"25","author":"Z Cai","year":"2019","unstructured":"Cai Z, Chen G, Zeng Y, Dong X, Li Z, Huang Y, Xin F, Qiu L, Xu H, Zhang W, Su X, Liu X, Liu J. Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma. Clin Cancer Res 2019;25(17):5284\u20135294. doi: https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-3477","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5470_CR5","doi-asserted-by":"publisher","first-page":"e0108247","DOI":"10.1371\/journal.pone.0108247","volume":"10","author":"KL Spindler","year":"2015","unstructured":"Spindler KL, Pallisgaard N, Andersen RF, Brandslund I, Jakobsen A. Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer. PLoS One 2015;10(4):e0108247. doi: https:\/\/doi.org\/10.1371\/journal.pone.0108247","journal-title":"PLoS One"},{"issue":"10","key":"5470_CR6","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/ijc.29612","volume":"137","author":"D Sefrioui","year":"2015","unstructured":"Sefrioui D, Perdrix A, Sarafan-Vasseur N, Dolfus C, Dujon A, Picquenot JM, Delacour J, Cornic M, Bohers E, Leheurteur M, Rigal O, Tennevet I, Thery JC, Alexandru C, Guillemet C, Moldovan C, Veyret C, Frebourg T, Di Fiore F, Clatot F. Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer. Int J Cancer 2015;137(10):2513\u20132519. doi: https:\/\/doi.org\/10.1002\/ijc.29612","journal-title":"Int J Cancer"},{"issue":"4","key":"5470_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s11523-015-0361-1","volume":"10","author":"G Kang","year":"2015","unstructured":"Kang G, Bae BN, Sohn BS, Pyo JS, Kang GH, Kim KM. Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor. Target Oncol 2015;10(4):597\u2013601. doi: https:\/\/doi.org\/10.1007\/s11523-015-0361-1","journal-title":"Target Oncol"},{"issue":"1","key":"5470_CR8","doi-asserted-by":"publisher","first-page":"16971","DOI":"10.1038\/s41598-019-53271-6","volume":"9","author":"JS Lee","year":"2019","unstructured":"Lee JS, Rhee TM, Pietrasz D, Bachet JB, Laurent-Puig P, Kong SY, Takai E, Yachida S, Shibata T, Lee JW, Park HC, Zang DY, Jeon K, Lee J, Kim M, Kim HS, Kang HJ, Lee YK. Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Sci Rep 2019;9(1):16971. doi: https:\/\/doi.org\/10.1038\/s41598-019-53271-6","journal-title":"Sci Rep"},{"issue":"7","key":"5470_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12032-016-0777-1","volume":"33","author":"T Li","year":"2016","unstructured":"Li T, Zheng Y, Sun H, Zhuang R, Liu J, Liu T, Cai W. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis. Med Oncol 2016;33(7):61. doi: https:\/\/doi.org\/10.1007\/s12032-016-0777-1","journal-title":"Med Oncol"},{"key":"5470_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.gene.2018.09.029","volume":"679","author":"L Chen","year":"2018","unstructured":"Chen L, Zhang Y, Cheng Y, Zhang D, Zhu S, Ma X. Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis. Gene 2018;679:328\u2013334. doi: https:\/\/doi.org\/10.1016\/j.gene.2018.09.029","journal-title":"Gene"},{"key":"5470_CR11","doi-asserted-by":"publisher","unstructured":"Watanabe K, Nakamura T, Kimura Y, Motoya M, Kojima S, Kuraya T, Murakami T, Kaneko T, Shinohara Y, Kitayama Y, Fukuda K, Hatanaka KC, Mitsuhashi T, Pittella-Silva F, Yamaguchi T, Hirano S, Nakamura Y, Low SK. Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer. Int J Mol Sci 2022;23(19). doi: https:\/\/doi.org\/10.3390\/ijms231911521","DOI":"10.3390\/ijms231911521"},{"issue":"1","key":"5470_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/ol.2025.15366","volume":"31","author":"A Harl\u00e9","year":"2026","unstructured":"Harl\u00e9 A, Gavoille C, Bouch\u00e9 O, Abdelghani MB, Plaza J, Spaeth D, Boudrant A, Ghiringhelli F, Villing AL, Borg C, Rouyer M, Husson M, Gilson P, Salleron J, Lambert A, Merlin JL. Sensitive cell-free DNA assay for accurate detection of RAS and BRAF mutations in liquid biopsies of patients with metastatic colorectal cancer: Final results of the multicentric ColoBEAM study. Oncol Lett 2026;31(1):13. doi: https:\/\/doi.org\/10.3892\/ol.2025.15366","journal-title":"Oncol Lett"},{"issue":"3_suppl","key":"5470_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1200\/JCO.2024.42.3_suppl.12","volume":"42","author":"J Tie","year":"2024","unstructured":"Tie J, Cohen JD, Wang Y, Ginestet PG, Wong R, Shapiro JD, Campbell R, Day F, Hayes TM, Aghmesheh M, Karapetis CS, Popoli M, Dobbyn L, Ptak J, Silliman N, Douville CB, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P. Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study. J Clin Oncol 2024;42(3_suppl):12\u201312. doi: https:\/\/doi.org\/10.1200\/JCO.2024.42.3_suppl.12","journal-title":"J Clin Oncol"},{"issue":"3","key":"5470_CR14","doi-asserted-by":"publisher","first-page":"e221093","DOI":"10.1001\/jamanetworkopen.2022.1093","volume":"5","author":"M Fakih","year":"2022","unstructured":"Fakih M, Sandhu J, Wang C, Kim J, Chen YJ, Lai L, Melstrom K, Kaiser A. Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer. JAMA Netw Open 2022;5(3):e221093. doi: https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.1093","journal-title":"JAMA Netw Open"},{"issue":"14","key":"5470_CR15","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1158\/1078-0432.Ccr-18-3663","volume":"25","author":"RC Coombes","year":"2019","unstructured":"Coombes RC, Page K, Salari R, Hastings RK, Armstrong A, Ahmed S, Ali S, Cleator S, Kenny L, Stebbing J, Rutherford M, Sethi H, Boydell A, Swenerton R, Fernandez-Garcia D, Gleason KLT, Goddard K, Guttery DS, Assaf ZJ, Wu HT, Natarajan P, Moore DA, Primrose L, Dashner S, Tin AS, Balcioglu M, Srinivasan R, Shchegrova SV, Olson A, Hafez D, Billings P, Aleshin A, Rehman F, Toghill BJ, Hills A, Louie MC, Lin CJ, Zimmermann BG, Shaw JA. Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence. Clin Cancer Res 2019;25(14):4255\u20134263. doi: https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-3663","journal-title":"Clin Cancer Res"},{"key":"5470_CR16","doi-asserted-by":"publisher","unstructured":"Abidoye O, Ahn DH, Borad MJ, Wu C, Bekaii-Saab T, Chakrabarti S, Sonbol MB. Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer. Cells 2025;14(3). doi: https:\/\/doi.org\/10.3390\/cells14030161","DOI":"10.3390\/cells14030161"},{"issue":"3","key":"5470_CR17","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1158\/1078-0432.Ccr-21-2404","volume":"28","author":"TV Henriksen","year":"2022","unstructured":"Henriksen TV, Tarazona N, Frydendahl A, Reinert T, Gimeno-Valiente F, Carbonell-Asins JA, Sharma S, Renner D, Hafez D, Roda D, Huerta M, Rosell\u00f3 S, Madsen AH, L\u00f8ve US, Andersen PV, Thorlacius-Ussing O, Iversen LH, Gotschalck KA, Sethi H, Aleshin A, Cervantes A, Andersen CL. Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences. Clin Cancer Res 2022;28(3):507\u2013517. doi: https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-2404","journal-title":"Clin Cancer Res"},{"key":"5470_CR18","doi-asserted-by":"publisher","unstructured":"Lee B TJ, Wang Y, et al. The potential role of serial circulating tumor DNA (ctDNA) testing after upfront surgery to guide adjuvant chemotherapy for early stage pancreatic cancer: The AGITG DYNAMIC-Pancreas trial. J Clin Oncol 2024;42(16_suppl)(107). doi: https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.107","DOI":"10.1200\/JCO.2024.42.16_suppl.107"},{"key":"5470_CR19","doi-asserted-by":"crossref","unstructured":"Kubendran S, Boland JL, Jurdi AA, Ween A, Baker G, Ma H, Baffa R, Li Z, Botta GP. Circulating tumor DNA and association with CAR-T cell therapy response in gastric and pancreatic cancer patients. American Society of Clinical Oncology, 2023.","DOI":"10.1200\/JCO.2023.41.16_suppl.4053"},{"issue":"8","key":"5470_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1001\/jamaoncol.2024.1575","volume":"10","author":"M Cecchini","year":"2024","unstructured":"Cecchini M, Salem RR, Robert M, Czerniak S, Blaha O, Zelterman D, Rajaei M, Townsend JP, Cai G, Chowdhury S, Yugawa D, Tseng R, Mejia Arbelaez C, Jiao J, Shroyer K, Thumar J, Kortmansky J, Zaheer W, Fischbach N, Persico J, Stein S, Khan SA, Cha C, Billingsley KG, Kunstman JW, Johung KL, Wiess C, Muzumdar MD, Spickard E, Aushev VN, Laliotis G, Jurdi A, Liu MC, Escobar-Hoyos L, Lacy J. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial. JAMA Oncol 2024;10(8):1027\u20131035. doi: https:\/\/doi.org\/10.1001\/jamaoncol.2024.1575","journal-title":"JAMA Oncol"},{"issue":"24","key":"5470_CR21","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","volume":"386","author":"J Tie","year":"2022","unstructured":"Tie J, Cohen JD, Lahouel K, Lo SN, Wang Y, Kosmider S, Wong R, Shapiro J, Lee M, Harris S, Khattak A, Burge M, Harris M, Lynam J, Nott L, Day F, Hayes T, McLachlan SA, Lee B, Ptak J, Silliman N, Dobbyn L, Popoli M, Hruban R, Lennon AM, Papadopoulos N, Kinzler KW, Vogelstein B, Tomasetti C, Gibbs P. Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer. N Engl J Med 2022;386(24):2261\u20132272. doi: https:\/\/doi.org\/10.1056\/NEJMoa2200075","journal-title":"N Engl J Med"},{"issue":"5","key":"5470_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/s41591-025-03579-w","volume":"31","author":"J Tie","year":"2025","unstructured":"Tie J, Wang Y, Lo SN, Lahouel K, Cohen JD, Wong R, Shapiro JD, Harris SJ, Khattak A, Burge ME, Lee M, Harris M, McLachlan SA, Horvath L, Karapetis C, Shannon J, Singh M, Yip D, Ananda S, Underhill C, Ptak J, Silliman N, Dobbyn L, Popoli M, Papadopoulos N, Tomasetti C, Kinzler KW, Vogelstein B, Gibbs P. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial. Nat Med 2025;31(5):1509\u20131518. doi: https:\/\/doi.org\/10.1038\/s41591-025-03579-w","journal-title":"Nat Med"},{"issue":"2","key":"5470_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.eururo.2023.06.007","volume":"85","author":"T Powles","year":"2024","unstructured":"Powles T, Assaf ZJ, Degaonkar V, Grivas P, Hussain M, Oudard S, Gschwend JE, Albers P, Castellano D, Nishiyama H, Daneshmand S, Sharma S, Sethi H, Aleshin A, Shi Y, Davarpanah N, Carter C, Bellmunt J, Mariathasan S. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma. Eur Urol 2024;85(2):114\u2013122. doi: https:\/\/doi.org\/10.1016\/j.eururo.2023.06.007","journal-title":"Eur Urol"},{"key":"5470_CR24","doi-asserted-by":"publisher","unstructured":"Zhang Y, Esmail A, Hassanain H, Dhillon V, Abdelrahim W, Al-Najjar E, Khasawneh B, Abdelrahim M. Correlative Analysis of Tumor-Informed Circulating Tumor DNA (ctDNA) and the Survival Outcomes of Patients with Pancreatic Adenocarcinoma. Biomedicines 2025;13(5). doi: https:\/\/doi.org\/10.3390\/biomedicines13051124","DOI":"10.3390\/biomedicines13051124"},{"issue":"3","key":"5470_CR25","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1245\/s10434-023-14751-2","volume":"31","author":"AM Eckhoff","year":"2024","unstructured":"Eckhoff AM, Kanu E, Fletcher A, Bao M, Aushev VN, Spickard E, Nussbaum DP, Allen PJ. Initial report: personalized circulating tumor DNA and survival in patients with resectable pancreatic cancer. Ann Surg Oncol 2024;31(3):1444\u20131446.","journal-title":"Ann Surg Oncol"},{"key":"5470_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejrad.2018.07.010","volume":"106","author":"LA Daamen","year":"2018","unstructured":"Daamen LA, Groot VP, Goense L, Wessels FJ, Borel Rinkes IH, Intven MPW, van Santvoort HC, Molenaar IQ. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis. Eur J Radiol 2018;106:128\u2013136. doi: https:\/\/doi.org\/10.1016\/j.ejrad.2018.07.010","journal-title":"Eur J Radiol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05470-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05470-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:13:55Z","timestamp":1789452835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05470-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5470"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05470-9","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Justin R Tse receives or recently received grant funding from GE HealthCare and Bayer AG. Justin R Tse is or was recently a consultant for Ascelia Pharma, Intuitive Surgical, Inc., and AbSolutions Med, Inc.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}